Understanding immunotherapy and its management
<p>A few tumours are exceptionally stubborn to oral chemotherapy. The endurance of tumours in a few cases is helped by checkpoint immunomodulation to keep up the unevenness between resistant reconnaissance and disease cell division. Checkpoint counteracting agent inhibitors, for example, again...
Saved in:
Main Authors: | Nadiminti Rajesh Kumar (Author), Sajid Alvi (Author) |
---|---|
Format: | Book |
Published: |
International Journal of Immunotherapy and Cancer Research - Peertechz Publications,
2021-01-12.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunotherapy and its advances in the management of head-and-neck cancer
by: Sajad Ahmad Buch, et al.
Published: (2019) -
Nanotechnology for boosting ovarian cancer immunotherapy
by: Prabhjot Kaur, et al.
Published: (2024) -
Cancer immunotherapy and its facilitation by nanomedicine
by: Chao Sui, et al.
Published: (2024) -
Adverse Events of Oncologic Immunotherapy and Their Management
by: Fedricker Diane Barber
Published: (2019) -
CANCER IMMUNOLOGY AND IMMUNOTHERAPY - UNDERSTANDING AND ADAPTATION THE CURRENT EVIDENCE TO OPTIMIZE PATIENT THERAPY OUTCOMES.
by: Orlin Savov, et al.
Published: (2015)